Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAUNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.25.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XADNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XABNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FT.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XALNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GY.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.10.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.99NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.343NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.17 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.25.1.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.409NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.310NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.362.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.162NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Y.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.86NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.154NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.41NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.137NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.446NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.76 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.398NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.163NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.3 (Theta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAVNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used